Monthly Archives: जुलाई 2010

ब्रिटेन में होम्योपैथी का विरोध – ब्रिटिश सरकार ने एन एच एस पर होम्योपैथी के अधिकार का बचाव किया (Government defends right to homeopathy on the NHS)

image ब्रिटिश सरकार ने दृढ़ता से एन एच एस पर होम्योपैथी के वित्तपोषण के लिए सांसदों और ब्रिटिश संसद की विज्ञान और तकनीकी समिति की रिपोर्ट  द्वारा मांगों को अस्वीकार कर दिया गया है और कहा  यह मरीज की  पसंद और  निर्णय पर निर्भर है कि वह कौन सी पद्दति को अपनाये ।

‘होम्योपैथी का  यूरोप में एक लंबा इतिहास  है और यूरोपीय संघ में भी होम्योपैथी  एक मान्यता प्राप्त है और काफ़ी यूरोपियन जनता तमाम विरोधों के बीच इसको पसंद करती रही है । जटिल केसों मे अकसर ऐलोपैथिक चिकित्सक होम्योपैथिक अस्पतालों मे केसों को रिफ़र करते देखे जाते है । समझा जाता है कि ब्रिटेन में सरकार होम्योपैथी पर हर साल लगभग 40 लाख पाउंड ख़र्च करती है । ब्रिटेन में लंदन, ब्रिस्टल, लिवरपूल और ग्लास्गो में होम्योपैथिक अस्पताल हैं । हाँलाकि ब्रिटिश संसद की विज्ञान और तकनीकी समिति की रिपोर्ट में ये स्वीकार किया गया कि आम लोगों में होम्योपैथी लोकप्रिय है और सर्वेक्षणों से पता लगता है कि इसका इस्तेमाल करनेवाले ७० प्रतिशत लोग इससे संतुष्ट भी हैं ।

‘सरकार का मानना है कि उपभोक्ताओं को जो होम्योपैथिक दवाओं का उपयोग करते हैं , उसके उद्देश्य के बारे में सूचित किया जाना चाहिए लेता है और  होम्योपैथिक दवा निर्माताओं को  गुणवत्ता और सुरक्षा के मानकों को बनाए रखना होगा । ’

देखें पूरी रिपोर्ट :  http://ning.it/bNXI3J

यह भी अवशय देखें :

 

Government defends right to homeopathy on the NHS

With thanks to Ian Quinn at Pulse Today 26.7.10

image The Government has strongly rejected demands by MPs for the funding of homeopathy on the NHS to be withdrawn, claiming it would fly in the face of patient choice and local decision-making.

In its response to a report from the House of Commons Science and Technology Committee, which issued a damning verdict on the practice and called for GPs to be barred from referring patients under the NHS, the Department of Heath said it would not be stepping in – despite MPs’ concerns over the lack of evidence and regulation of homeopathic treatments.

MPs had called not only for doctors to be barred from referring patients to homeopathic hospitals or homeopaths, but for the MHRA to intervene and to apply the same standards of regulation as for medicines, which they said would remove any medical claim supporters of homeopathy had.

But in its response today the DH said: ‘It is not appropriate for the Department of Health to remove the right of PCTs to make these decisions on a case-by-case basis.’

‘Capital investment decisions in the NHS are planned and decided at local level. The commissioning plans of local PCTs set out the type of services that need to be provided and therefore drive decisions about the nature of new facilities needed, or the need to maintain, update or replace existing facilities.’

The committee had also called for an investigation into the cost of homeopathy to the NHS and for new research into the evidence-base for homeopathy, but this too was rejected.

MPs had wanted regulators to ‘remove any medical claim and any implied endorsement of efficacy by the MHRA’ by ensuring the same evidence of efficacy used to assess conventional medicines was used, but the Government said this would potentially deal a fatal blow to the homeopathy market and limit consumer choice.

‘Homeopathy has a long tradition in Europe and is a recognised and widely used system of medicine across the EU,’ it said.

‘The Government takes the view that consumers who choose to use homeopathic medicines should be fully informed about their purpose and assured that standards of quality and safety are maintained. If homeopathic medicines were not subject to any kind of regulatory control consumers would not have access to such information or assurances.’

‘Conversely, if regulation was applied to homeopathic medicines as understood in the context of conventional pharmaceutical medicines, these products would have to be withdrawn from the market as medicines. This would constrain consumer choice and, more importantly, risk the introduction of unregulated, poor quality and potentially unsafe products on the market to satisfy consumer demand.’

Brian Kaplan – London | 26 Jul 10

This is truly marvellous news – simply the most heartening thing I’ve read in PULSE for years.

The government’s decision is a victory for liberty and democracy in this country and a slap in the face for those who would seek to thwart the rights of GPs to send patients to fully qualified doctors on the NHS who use homeopathic medicine.

Government Response to the Science and Technology Committee report ‘Evidence Check 2: Homeopathy’

26th July 2010

http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_117810

Other reports:

Homeopathy will not be banned – the Telegraph 26.7.10

Courtesy : Sue Young

Advertisements

होम्योपैथी औषधि ’ बेलोडोना ’ का दिमागी ज्वर मे सफ़ल रोल – एक शोध पत्र (New Study Proves Homeopathy Prevents Japanese Encephalitis)

 

 image

हाल ही  में स्कूल आफ ट्रापिकल मेडिसिन, कोलकाता के माइक्रोबायलोजी विभाग और केंद्र सरकार के संयुक्त तत्वावधान में प्रयोगशाला परीक्षण हुआ। इसमें चूहों के शरीर में पहले इंसेफ्लाइटिस के वायरस को प्रवेश कराया गया। इसके बाद इन पर बेलाडोना के असर का अध्ययन हुआ। नतीजे बेहतर आये और अमेरिकन जरनल आफ इंफेक्शियस डिजीज ने इस माह अपने ताजा अंक में प्रयोगशाला परीक्षण ने नतीजों को प्रकाशित किया है। देखे यहाँ

CCRH ( सेन्ट्रल काउन्सिल आफ़ होम्योपैथी ) द्वारा प्रयोजित विभिन्न सेन्ट्रर पर चल रहे क्लीनिकल और प्रयोगशाला परीक्षण में जे ई ( दिमागी बुखार ) पर होम्योपैथिक दवाएं काफी प्रभावी साबित हुई हैं। नतीजों से उत्साहित होम्योपैथिक विभाग ने जेई और स्वाइन फ्लू से लोगों को प्रतिरक्षित करने की एक विस्तृत योजना शासन को सौंपी है। असिस्टेंट निदेशक डा. जेपी सिंह के अनुसार  बीते आठ वर्षो से गोरखपुर, महाराजगंज और देवरिया में जेई समेत अन्य सभी प्रकार के दिमागी बुखार के रोगियों को विशेषज्ञ डाक्टरों व कर्मचारियों द्वारा होम्योपैथिक दवा बेलाडोना दी गयी। मरीजों पर लगातार नजर रखी गयी। इसके नतीजे उत्साहवर्धक हैं। दवा के सेवन से न केवल ऐसे रोगी जल्दी ठीक हुए बल्कि अन्य में दिमागी बुखार के प्रति अप्रत्याशित ढंग से प्रतिरोधक क्षमता विकसित हुई है। क्लीनिकल ट्रायल के इन परिणामों पर सेंट्रल काउंसिल फाररिसर्च इन होम्योपैथी (सीसीआरएच) ने भी अपनी मुहर लगा दी है।

 

New Study Proves Homeopathy Prevents Japanese Encephalitis

image Decreased Intensity of Japanese Encephalitis Virus Infection in Chick Chorioallantoic Membrane Under Influence of Ultradiluted Belladonna Extract. American Journal of Infectious Diseases 6 (2): 24-28, 2010.

The homeopathic remedy Belladonna is effective in preventing Japanese Encephalitis (JE), says a  recent study conducted by the Department of Microbiology at the School of Tropical Medicine in Kolkata, the Department of Clinical and Experimental Pharmacology at the School of Tropical Medicine in Kolkata, the University of Health Sciences in Kolkata, the Department of Pathology and Microbiology in West Bengal, in collaboration with the the Drug Proving Research Centre of the Central Council for Research in Homeopathy (CCRH), and the Government of India in Kolkata, and the Department of AYUSH Ministry of Health in New Delhi.

Abstract: Problem statement: No specific antiviral therapy is currently available despite an emergence and resurgence of Japanese encephalitis in South-East Asian Countries.

There are only few recent studies, which were aimed to treat Japanese encephalitis with newer drugs. There is thus a real need for study on antiviral agents that can reduce the toll of death and neurological sequelae resulting from infection with this virus.

Approach: Optimum dilution of the JE virus was determined which could produce significant number of pocks on Chorioallantoic Membrane (CAM). Then ultradiluted Belladonna preparations were used to see their inhibitory action on JE virus infection in CAM.

Results: Ultradiluted Belladonna showed significantly decreased pock count in CAM in comparison to JE virus control.

Conclusion: Ultradiluted Belladonna could inhibit JE virus infection in CAM, which may be mediated through glycosidase inhibitory role of calystegines present in Belladonna.

Study conducted by: 1Bhaswati Bandyopadhyay, 2Satadal Das, 1Milan Sengupta, 3Chandan Saha, 4Kartick Chandra Das, 4Debabrata Sarkar and 5Chaturbhuj Nayak. 1Department of Microbiology, Virology Unit, School of Tropical Medicine, Kolkata-700073, India. 2Department of Pathology and Microbiology, D.N. De H. Medical College, West Bengal University of Health Sciences, Kolkata-700046, India. 3Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata-700073, India. 4Drug Proving Research Centre, CCRH, Government of India, Kolkata-700 046, India. 5Department of AYUSH, Ministry of Health, CCRH, Government of India, JLN Anudandhan Bhawan, 61-65 Intitutional Area, Janakpuri, New Delhi 110058.